CapitalBio Thalassemia Gene Mutations Detection Kit is designed for a rapid and accurate genotyping of Thalassemia. Thalassemia is one of the most common monogenic hereditary blood diseases. It is caused by the deletion of or the mutation in globin-encoding genes which leads to hemolytic anemia. Its symptoms include bone deformities, enlarged spleen, iron overload, and lowered growth rate. Thalassemia major could result in death. Approximately 4.83% of the human population are carriers of Thalassemia-related gene mutations. As many as 500,000 babies with Thalassemia major are born every year. Genetic counseling is key to the prevention of Thalassemia. Covering 25 Thalassemia-related gene mutations, CapitalBio Thalassemia Gene Mutations Detection Kit is a useful tool for genetic counseling.
● High Throughput: As many as 25 gene mutations are detected simultaneously. α-Thalassemia and β-Thalassemia do not need to be detected separately.
● Rapid Detection: It takes only 4.5 hours to finish the testing process.
● Automatic Operation: Hybridization, washing, and scanning are all finished by instruments. No developing operation is needed. Reports are generated automatically by the software.
● High Traceability: Test results can be saved permanently and therefore are highly traceable.